{{Infobox drug
| IUPAC_name = 3-((3''R'')-3-{[(4-fluorophenyl)sulfonyl]amino}-1,2,3,4-tetrahydro-9''H''-carbazol-9-yl)propanoic acid
| image = Ramatroban.svg
| alt = 
| caption =

<!-- Clinical data -->
| pronounce =
| tradename = Baynas
| Drugs.com = {{Drugs.com|international|ramatroban}}
| MedlinePlus = 
| pregnancy_category = 
| routes_of_administration = Oral ([[Tablet (pharmacy)|tablets]])
| legal_status = Rx-only <small>([[Japan|JP]])</small>

<!-- Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 
| metabolites = 
| onset = 
| elimination_half-life = 
| duration_of_action= 
| excretion =

<!-- Identifiers -->
| CAS_number = 116649-85-5
| ATCvet = 
| ATC_prefix = None
| ATC_suffix = 
| PubChem = 123879
| DrugBank = 
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = P1ALI72U6C
| IUPHAR_ligand = 1910
| ChEMBL = 361812
| ChemSpiderID = 110413
| KEGG = D01128

<!-- Chemical data -->
| chemical_formula  = 
| C=21 | H=21 | F=1 | N=2 | O=4 | S=1
| molecular_weight  = 416.46 g/mol
| smiles = C1CC2=C(CC1NS(=O)(=O)C3=CC=C(C=C3)F)C4=CC=CC=C4N2CCC(=O)O
| StdInChI = 1S/C21H21FN2O4S/c22-14-5-8-16(9-6-14)29(27,28)23-15-7-10-20-18(13-15)17-3-1-2-4-19(17)24(20)12-11-21(25)26/h1-6,8-9,15,23H,7,10-13H2,(H,25,26)/t15-/m1/s1
| StdInChIKey = LDXDSHIEDAPSSA-OAHLLOKOSA-N
}}

'''Ramatroban''' ([[International Nonproprietary Name|INN]]) is a [[thromboxane receptor antagonist]].<ref name="pmid12649388">{{cite journal |author=Sugimoto H |title=An orally bioavailable small molecule antagonist of CRTH2, ramatroban (BAY u3405), inhibits prostaglandin D2-induced eosinophil migration in vitro |journal=J. Pharmacol. Exp. Ther. |volume=305 |issue=1 |pages=347–52 |date=April 2003 |pmid=12649388 |doi=10.1124/jpet.102.046748 |url=http://jpet.aspetjournals.org/cgi/pmidlookup?view=long&pmid=12649388 |name-list-format=vanc|author2=Shichijo M |author3=Iino T |display-authors=3 |last4=Manabe |first4=Y |last5=Watanabe |first5=A |last6=Shimazaki |first6=M |last7=Gantner |first7=F |last8=Bacon |first8=KB}}</ref>

It is also a [[DP2 receptor|DP<sub>2</sub> receptor]] [[receptor antagonist|antagonist]].<ref name="pmid18837743">{{cite journal |author=Royer JF |title=A novel antagonist of prostaglandin D2 blocks the locomotion of eosinophils and basophils |journal=Eur. J. Clin. Invest. |volume=38 |issue=9 |pages=663–71 |date=September 2008 |pmid=18837743 |doi=10.1111/j.1365-2362.2008.01989.x |url=http://www3.interscience.wiley.com/resolve/openurl?genre=article&sid=nlm:pubmed&issn=0014-2972&date=2008&volume=38&issue=9&spage=663 |name-list-format=vanc|author2=Schratl P |author3=Carrillo JJ |display-authors=3 |last4=Jupp |first4=R. |last5=Barker |first5=J. |last6=Weyman-Jones |first6=C. |last7=Beri |first7=R. |last8=Sargent |first8=C. |last9=Schmidt |first9=J. A.}}</ref>

It is indicated for the treatment of [[coronary artery disease]].<ref name="pmid2260140">{{cite journal |vauthors=Fiedler VB, Seuter F, Perzborn E |title=Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease |journal=Stroke |volume=21 |issue=12 Suppl |pages=IV149–51 |date=December 1990 |pmid=2260140 |doi= |url=http://pt.wkhealth.com/pt/re/stroke/pdfhandler.00007670-199012001-00037.pdf }}</ref> It has also been used for the treatment of [[asthma]].<ref name="pmid8950952">{{cite journal |vauthors=Endo S, Akiyama K |title=[Thromboxane A2 receptor antagonist in asthma therapy] |language=Japanese |journal=Nippon Rinsho |volume=54 |issue=11 |pages=3045–8 |date=November 1996 |pmid=8950952 |doi= |url=}}</ref>

It was developed by the German pharmaceutical company [[Bayer|Bayer AG]] and is co-marketed in [[Japan]] by Bayer and Nippon Shinyaku Co. Ltd. under the trade name '''Baynas'''.

==References==
{{Reflist|2}}

==External links==
* {{ja icon}} [http://www.nippon-shinyaku.co.jp/assets/files/pdfs/medicine/product/ha/baynas/interview_baynas_t.pdf Baynas Tablets Prescribing Information]

{{Antithrombotics}}
{{Asthma and copd rx}}
{{Prostanoidergics}}

[[Category:Antiplatelet drugs]]
[[Category:Sulfonamides]]

{{respiratory-system-drug-stub}}
{{blood-drug-stub}}